{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:07:58Z","timestamp":1787062078156,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02000","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T02:03:06Z","timestamp":1537236186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Treatment of Granulomas in Patients With Ataxia Telangiectasia"],"prefix":"10.3389","volume":"9","author":[{"given":"Sandra","family":"Woelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Valesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Bakhtiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pommerening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Pfeffermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.21.4.526","article-title":"Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection","volume":"21","author":"Boder","year":"1958","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ppul.22817","article-title":"Infections of the respiratory system in patients with ataxia-telangiectasia","volume":"49","author":"Schroeder","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/08977194.2014.939805","article-title":"Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia","volume":"32","author":"Voss","year":"2014","journal-title":"Growth Fact"},{"key":"B4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13023-015-0373-z","article-title":"Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study","volume":"10","author":"Pommerening","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/pr.2016.19","article-title":"Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort","volume":"79","author":"Nissenkorn","year":"2016","journal-title":"Pediatr Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/336577a0","article-title":"Localization of an ataxia-telangiectasia gene to chromosome 11q22-23","volume":"336","author":"Gatti","year":"1988","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/hmg\/4.11.2025","article-title":"The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species","volume":"4","author":"Savitsky","year":"1995","journal-title":"Hum Mol Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrm2514","article-title":"Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer","volume":"9","author":"Lavin","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","article-title":"Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype","volume":"128","author":"Micol","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jaad.2012.12.950","article-title":"Dermatologic manifestations of ataxia-telangiectasia syndrome","volume":"68","author":"Greenberger","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nature01385","article-title":"Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing","volume":"421","author":"Wong","year":"2003","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1365-2133.1998.02432.x","article-title":"Granulomatous skin lesions in a patient with ataxia telangiectasia","volume":"139","author":"Sent\u00fcrk","year":"1998","journal-title":"Br J Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11882-005-0008-x","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"5","author":"Morimoto","year":"2005","journal-title":"Curr Allergy Asthma Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000330335","article-title":"Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation?","volume":"223","author":"Chiam","year":"2011","journal-title":"Dermatol"},{"key":"B16","first-page":"138","article-title":"Necrobiotic cutaneous granulomas in Nijmegen breakage syndrome","volume":"22","author":"Pasic","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2230.1993.tb02251.x","article-title":"Cutaneous granuloma with ataxia telangiectasia\u2013a case report and review of literature","volume":"18","author":"Joshi","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.det.2015.03.014","article-title":"Foreign body granulomas","volume":"33","author":"Molina-Ruiz","year":"2015","journal-title":"Dermatol Clin"},{"key":"B19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000246117","article-title":"Cutaneous granulomas as a presenting sign in ataxia-telangiectasia","volume":"194","author":"Drolet","year":"1997","journal-title":"ermatol Basel Switz"},{"key":"B20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0022-3476(05)83043-4","article-title":"Cutaneous granulomatous lesions in patients with ataxia-telangiectasia","volume":"119","author":"Paller","year":"1991","journal-title":"J Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/pde.12411","article-title":"Healing of granulomatous skin changes in ataxia-telangiectasia after treatment with intravenous immunoglobulin and topical mometasone 0","volume":"31","author":"Privette","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaad.2010.06.060","article-title":"Infliximab in the treatment of a child with cutaneous granulomas associated with ataxia telangiectasia","volume":"65","author":"Mitra","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s10875-014-0079-3","article-title":"Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency","volume":"34","author":"Franxman","year":"2014","journal-title":"J Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/INF.0000000000001646","article-title":"Infections Associated with streptococcus constellatus in children","volume":"36","author":"Faden","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/01677063.2011.592553","article-title":"Workshop report: European workshop on ataxia-telangiectasia, Frankfurt","volume":"25","author":"Zielen","year":"2011","journal-title":"J Neurogenet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/pai.12527","article-title":"Chronic granulomatous disease: clinical, molecular, and therapeutic aspects","volume":"27","author":"Chiriaco","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaci.2011.05.024","article-title":"Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-\u03b1 mAbs","volume":"128","author":"Moshous","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2169\/internalmedicine.46.6414","article-title":"Fever of unknown origin in a patient with common variable immunodeficiency associated with multisystemic granulomatous disease","volume":"46","author":"Fern\u00e1ndez-Ruiz","year":"2007","journal-title":"Intern Med Tokyo Jpn"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1542\/peds.114.2.462","article-title":"Gastrointestinal involvement in chronic granulomatous disease","volume":"114","author":"Marciano","year":"2004","journal-title":"Pediatrics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cid\/ciw675","article-title":"Cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in children with primary immunodeficiencies","volume":"64","author":"Neven","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","article-title":"Ataxia-telangiectasia: immunodeficiency and survival","volume":"178","author":"van Os","year":"2017","journal-title":"Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/humu.22016","article-title":"Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study","volume":"33","author":"Verhagen","year":"2012","journal-title":"Hum Mutat"},{"key":"B34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8(+) T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2249.2002.01830.x","article-title":"Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia","volume":"129","author":"Schubert","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2249.2006.03221.x","article-title":"Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia","volume":"146","author":"Reichenbach","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaci.2013.01.053","article-title":"Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity","volume":"131","author":"Driessen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1182\/blood-2002-03-0976","article-title":"Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia","volume":"100","author":"Giovannetti","year":"2002","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"O656","DOI":"10.1111\/1469-0691.12573","article-title":"Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency","volume":"20","author":"Bodemer","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jaci.2016.06.030","article-title":"Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies","volume":"138","author":"Perelygina","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2015.00212","article-title":"Anatomy of a discovery: m1 and m2 macrophages","volume":"6","author":"Mills","year":"2015","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2016.09.054","article-title":"DNA damage signaling instructs polyploid macrophage fate in granulomas","volume":"167","author":"Herrtwich","year":"2016","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.disamonth.2017.07.001","article-title":"A comprehensive review and update on Crohn's disease","volume":"64","author":"Gajendran","year":"2018","journal-title":"Dis Mon"},{"key":"B44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.autrev.2007.03.009","article-title":"Potential target of infliximab in autoimmune and inflammatory diseases","volume":"6","author":"Atzeni","year":"2007","journal-title":"Autoimmun Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/ecco-jcc\/jjv096","article-title":"Infliximab-related infusion reactions: systematic review","volume":"9","author":"Lichtenstein","year":"2015","journal-title":"J Crohns Colitis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jaci.2006.01.034","article-title":"Etanercept treatment of cutaneous granulomas in common variable immunodeficiency","volume":"117","author":"Lin","year":"2006","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02000\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T15:30:05Z","timestamp":1662046205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02000\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2018.02000"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02000","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1007\/s12311-026-01994-4","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"article-number":"2000"}}